26043075|t|Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways.
26043075|a|Transient receptor potential vanilloid 4 (TRPV4) is a calcium-permeable cation channel that is sensitive to cell swelling, arachidonic acid and its metabolites, epoxyeicosatrienoic acids, which are associated with cerebral ischemia. The activation of TRPV4 induces cytotoxicity in many types of cells, accompanied by an increase in the intracellular free calcium concentration. TRPV4 activation modulates the mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3 kinase (PI3K)/ protein kinase B (Akt) signaling pathways that regulate cell death and survival. Herein, we examined TRPV4-induced neuronal apoptosis by intracerebroventricular (ICV) injection of a TRPV4 agonist (GSK1016790A) and assessed its involvement in cerebral ischemic injury. ICV injection of GSK1016790A dose-dependently induced apoptosis in the mouse hippocampi (GSK-injected mice). The protein level of phosphorylated p38 MAPK (p-p38 MAPK) was markedly increased and that of phosphorylated c-Jun N-terminal protein kinase (p-JNK) was virtually unchanged. TRPV4 activation also decreased Bcl-2/Bax protein ratio and increased the cleaved caspase-3 protein level, and these effects were blocked by a PI3K agonist and a p38 MAPK antagonist, but were unaffected by a JNK antagonist. ICV injection of the TRPV4 antagonist HC-067047 reduced brain infarction after reperfusion for 48 h in mice with middle cerebral artery occlusion (MCAO). In addition, HC-067047 treatment attenuated the decrease in the phosphorylated Akt protein level and the increase in p-p38 MAPK protein level at 48 h after MCAO, while the increase in p-JNK protein level remained unchanged. Finally, the decreased Bcl-2/Bax protein ratio and the increased cleaved caspase-3 protein level at 48 h after MCAO were markedly attenuated by HC-067047. We conclude that activation of TRPV4 induces apoptosis by downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways, which is involved in cerebral ischemic injury. 
26043075	116	119	Akt	Gene	11651
26043075	137	145	p38 MAPK	Gene	26416
26043075	208	213	TRPV4	Gene	63873
26043075	220	227	calcium	Chemical	MESH:D002118
26043075	289	305	arachidonic acid	Chemical	MESH:D016718
26043075	327	352	epoxyeicosatrienoic acids	Chemical	-
26043075	380	397	cerebral ischemia	Disease	MESH:D002545
26043075	417	422	TRPV4	Gene	63873
26043075	431	443	cytotoxicity	Disease	MESH:D064420
26043075	521	528	calcium	Chemical	MESH:D002118
26043075	544	549	TRPV4	Gene	63873
26043075	619	649	phosphatidyl inositol 3 kinase	Gene	18708
26043075	676	679	Akt	Gene	11651
26043075	759	764	TRPV4	Gene	63873
26043075	840	845	TRPV4	Gene	63873
26043075	855	866	GSK1016790A	Chemical	MESH:C530602
26043075	900	924	cerebral ischemic injury	Disease	MESH:D017202
26043075	943	954	GSK1016790A	Chemical	MESH:C530602
26043075	997	1002	mouse	Species	10090
26043075	1015	1018	GSK	Chemical	-
26043075	1028	1032	mice	Species	10090
26043075	1071	1079	p38 MAPK	Gene	26416
26043075	1083	1091	p38 MAPK	Gene	26416
26043075	1178	1181	JNK	Gene	26419
26043075	1208	1213	TRPV4	Gene	63873
26043075	1240	1245	Bcl-2	Gene	12043
26043075	1246	1249	Bax	Gene	12028
26043075	1290	1299	caspase-3	Gene	12367
26043075	1370	1378	p38 MAPK	Gene	26416
26043075	1416	1419	JNK	Gene	26419
26043075	1453	1458	TRPV4	Gene	63873
26043075	1470	1479	HC-067047	Chemical	MESH:C573308
26043075	1488	1504	brain infarction	Disease	MESH:D020520
26043075	1535	1539	mice	Species	10090
26043075	1545	1577	middle cerebral artery occlusion	Disease	MESH:D020244
26043075	1579	1583	MCAO	Disease	MESH:D020244
26043075	1599	1608	HC-067047	Chemical	MESH:C573308
26043075	1665	1668	Akt	Gene	11651
26043075	1705	1713	p38 MAPK	Gene	26416
26043075	1742	1746	MCAO	Disease	MESH:D020244
26043075	1772	1775	JNK	Gene	26419
26043075	1833	1838	Bcl-2	Gene	12043
26043075	1839	1842	Bax	Gene	12028
26043075	1883	1892	caspase-3	Gene	12367
26043075	1921	1925	MCAO	Disease	MESH:D020244
26043075	1954	1963	HC-067047	Chemical	MESH:C573308
26043075	1996	2001	TRPV4	Gene	63873
26043075	2043	2046	Akt	Gene	11651
26043075	2064	2072	p38 MAPK	Gene	26416
26043075	2114	2138	cerebral ischemic injury	Disease	MESH:D017202
26043075	Association	MESH:D020520	63873
26043075	Positive_Correlation	26416	63873
26043075	Negative_Correlation	MESH:C573308	26416
26043075	Positive_Correlation	MESH:C573308	11651
26043075	Negative_Correlation	MESH:C573308	MESH:D020520
26043075	Positive_Correlation	MESH:C573308	26419
26043075	Association	MESH:D017202	63873
26043075	Association	18708	63873
26043075	Positive_Correlation	MESH:D002118	MESH:D064420
26043075	Negative_Correlation	MESH:C573308	12028
26043075	Association	MESH:D002545	63873
26043075	Association	MESH:D016718	63873
26043075	Positive_Correlation	MESH:C530602	63873
26043075	Positive_Correlation	MESH:C530602	26416
26043075	Negative_Correlation	MESH:C573308	63873
26043075	Positive_Correlation	MESH:D064420	63873
26043075	Negative_Correlation	12043	63873
26043075	Negative_Correlation	MESH:C573308	12043
26043075	Association	11651	63873
26043075	Negative_Correlation	MESH:C573308	12367
26043075	Negative_Correlation	MESH:C573308	MESH:D020244
26043075	Positive_Correlation	12367	63873
26043075	Negative_Correlation	12028	63873
26043075	Association	MESH:D017202	11651
26043075	Association	MESH:D016718	MESH:D002545
26043075	Positive_Correlation	MESH:D002118	63873

